SCOTUS: “The More a Party Claims for Itself the More it Must Enable”
Intellectual Property Law Blog
MAY 22, 2023
After a nine-year saga, beginning when Amgen sued Sanofi for allegedly infringing two of its patents in 2014, the Supreme Court held that Amgen’s asserted patents failed to satisfy the enablement requirement under 35 U.S.C. § 112(a), and are thus invalid. In re Wands , 858 F.2d 2d at 737, 8 USPQ2d at 1404 (Fed.
Let's personalize your content